Consolidated Statements of Cash Flows (USD $)	12 Months Ended		158 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (1,199,057)	$ (665,113)	$ (13,387,041)
Adjustments to reconcile net loss to net cash used in operating activities
Fair value of options issued in exchange for services	343,674	96,032	2,417,232
Accretion of interest on deferred finance charges	13,625	27,149	453,625
Accretion of discount on notes payable	4,957	17,416	443,236
Salary due to stockholder contributed to capital			15,000
Amortization and depreciation	13,471	10,904	530,055
Gain on disposition of assets			(4,722)
Gain on debt forgiveness	(156,110)	(184,242)	(340,352)
Stock issued in exchange for services	46,500	30,000	553,760
Financing expenses paid directly from stock proceeds			5,270
Amortization of deferred consulting fees			40,800
(Increase) decrease in assets
Accounts receivable	(3,473)	10,193	(3,473)
Inventory	15,157	(11,451)	19,980
Prepaid expenses	(232,240)	21,936	(350,000)
Increase in liabilities
Accounts payable and accrued expenses	786,436	333,291	2,567,362
Net cash used in operating activities	(367,060)	(313,885)	(7,039,268)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment	(2,360)		(38,109)
Purchase of intangibles	(6,665)	(3,577)	(224,134)
Proceeds from sale of assets			6,738
Net cash used in investing activities	(9,025)	(3,577)	(255,505)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of common stock	2,060,000	400,000	6,551,447
Proceeds from exercise of stock options	13,113	10,000	255,482
Proceeds issuance of stock options			15,000
Proceeds from exercise of warrants	50,000		105,500
Proceeds from issuance of warrants	1,000,000		1,000,000
Proceeds from issuance of notes payable	200,000		2,789,000
Repayments of notes payable	(6,251)	(58,500)	(202,751)
Payment for treasury stock		(17,795)	(17,795)
Debt issuance costs			(62,000)
Stock issuance costs		(40,000)	(144,760)
Net cash provided by financing activities	3,316,862	293,705	10,289,123
NET DECREASE IN CASH AND CASH EQUIVALENTS	2,940,777	(23,757)	2,994,350
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	53,573	77,330
CASH AND CASH EQUIVALENTS - END OF PERIOD	2,994,350	53,573	2,994,350
Cash paid during the year for:
Interest		6,557	39,440
Income taxes
Return of shares of common stock related to purchase price adjustment
Common stock			(1,000)
Additional paid-in capital			(353,000)
Intangible assets			(354,000)
Issuance of common stock and stock options for acquisition of subsidiary			738,000
Proceeds from common stock sales applied directly to debt and financing expenses repayment			55,270
Fair value of warrants issued for deferred finance charges			392,376
Fair value of stock issued for conversion of notes payable and accrued interest	581,564		893,605
Fair value of stock issued for purchase of assets	100,000		100,000
Fair value of warrants issued for purchase of assets	100,000		100,000
Fair value of stock issued for licensing costs	100,000		100,000
Fair value of warrants issued for licensing costs	300,000		300,000
Fair value of beneficial conversion option			400,000
Fair value of warrants issued as debt discount		21,275	78,043
Issuance of common stock for stock issuance costs		2,100	2,100
Issuance of options as stock cost for treasury stock		5,594	5,594
Forgiveness of debt-related party treated as additional paid in capital	$ 349,000		$ 349,000